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Background. Human rhinoviruses (HRV), human enteroviruses (HEV) and human 
parechoviruses (HPeV) have been linked to acute otitis media (AOM). This association was 
evaluated in a prospective birth cohort setting. 
Methods. 542 healthy infants were followed up from birth to the age of 3 years in the 
DIABIMMUNE study in Finland and Estonia. Stool samples were collected monthly and analyzed 
for HRV, HEV and HPeV. Nasal swab samples were collected at the age of 3, 6, 12, 18, 24 and 
36 months, and screened for HRV and HEV. Parents recorded all AOM diagnoses in a diary. The 
association between virus detection in samples and AOM episodes was assessed by univariate 
and multivariate logistic regression.  
Results. Altogether 1066 AOM episodes were recorded during the study period. 21%, 5% and 
4% of the stool samples tested positive for HRV, HEV and HPeV, respectively. Of the nasal swab 
samples, 23% were positive for HRV and 2% for HEV. HRV and HPeV positivity of stool samples 
was associated with experiencing an AOM episode within two weeks before or after obtaining the 
stool sample (adjusted OR 1.42 [95% CI 1.00-2.01] for HRV and adjusted OR 2.00 [95% CI 1.12-
3.55] for HPeV). 
Conclusion. HRV, HEV and HPeV infections occur frequently in early childhood. These 
viruses may play an independent role in the development of AOM in children. 
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ABBREVIATIONS  
AOM Acute otitis media 
CI Confidence interval 
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HRV Human rhinovirus 
IgA Immunoglobulin A 
MEE Middle ear effusion 
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OM Otitis media 
OME Otitis media with effusion 
OR Odds ratio 
PCV  Pneumococcal conjugate vaccine 
qPCR Quantitative polymerase chain reaction 
rAOM Recurrent acute otitis media 
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1. INTRODUCTION 
Acute otitis media (AOM) occurs worldwide and primarily affects pediatric populations. 
Among children, AOM is the most common reason for the prescription of antibiotics, and 
along with upper respiratory infections (URIs), the leading cause for doctors’ visits.[1, 2] 
URIs and AOM are closely linked: URIs, most of which have a viral etiology, are often 
complicated by AOM, especially among children.[3, 4] In studies carried out among 
pediatric populations, approximately one third of all URIs have been complicated by 
AOM, which usually occurs within the first seven days of URI onset.[3-6] The significant 
burden of viral URIs leads to the high incidence of AOM, which is one of the most 
common diseases in childhood. Furthermore, children encountering AOM early in life 
have been shown to be at increased risk of recurrent AOM later on.[7] Otitis media results 
in the widespread use of antibiotics as well as otologic surgery, causing significant 
financial losses to the families of the children and society.[8]  
Generally, AOM is acknowledged to be a bacterial complication of viral URI. However, 
viruses alone or together with bacterial co-pathogens have also been shown to cause 
AOM.[1, 9, 10] Of the large variety of viruses causing URIs, picornaviruses have been 
found to be among the most common causes, with human rhinoviruses (HRV) accounting 
for up to 73% of all respiratory infections recorded during the first year of life.[11, 12] 
HRVs as well as human enteroviruses (HEV) and human parechoviruses (HPeV) have 
been linked to AOM in a number of studies. In Finnish and Australian studies, HRVs and 
HEVs were the predominant viruses detected in children with AOM and recurrent 
AOM.[9, 13, 14] HPeVs have been found to play a smaller role in the development of 
AOM.[15-17] 
The aforementioned studies have mostly relied on methods based on reverse transcriptase 
polymerase chain reaction (RT-PCR) assays, the high sensitivity of which has led to the 
questioning of the clinical relevance of the results. These viruses detectable with PCR-
based methods have also been found in children without concurrent respiratory 
symptoms.[18] Hence, the presence of HRVs, HEVs and HPeVs in respiratory or stool 
samples alone does not establish causality of the concurrent illness. In order to further 
investigate the possible causal relationship between virus findings and clinical symptoms, 
 2 
it is important to conduct studies in which the overall frequency of HRV, HEV and HPeV 
infections is compared between children who develop AOM and those who do not.  
The aim of this study was to assess the association between HRV, HEV and HPeV 
infections and AOM in a cohort of healthy children who were followed from birth to the 
age of 3 years. Nasal swab and stool samples were collected regularly from the children 
and analyzed for HRVs, HEVs and HPeVs using sensitive RT-PCR methods. The 
infections diagnosed during the first year of life were of special interest, as AOM 
experienced early in life can predispose to recurrent AOM later. Furthermore, the 
inclusion of nasal swab samples in this study was expected to bring additional information 
on the epidemiology of HRV, HEV and HPeV infections as compared to the study 
recently published by our study group.[19] AOM episodes were recorded during the 
follow-up, allowing the evaluation of the association between virus-positive findings to 
AOM episodes in an unbiased manner.  
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2. REVIEW OF LITERATURE  
This chapter presents a summary of selected aspects of AOM most relevant to the topic 
of the study. Above all, the review of literature focuses on the role of viruses, and 
especially picornaviruses, in the development of AOM.  
2.1 Definitions of otitis media 
In general, the term otitis media (OM) refers to the inflammation of the middle ear. AOM 
is defined as the presence of middle ear effusion (MEE) together with the acute onset of 
signs and symptoms of inflammation of the middle ear and tympanic membrane, such as 
otalgia, otorrhea, fever, irritability and other symptoms typical of URIs.[1, 20] Recurrent 
AOM (rAOM) is referred to when a person encounters three or more AOM episodes in a 
period of six months, or four or more in 12 months.[21]  Otitis media with effusion 
(OME), another stage of the OM continuum, is a condition with MEE, but without acute 
signs or symptoms of infections as seen in AOM. The term chronic OME (COME) is 
used when the condition persists for at least three months. In the case of chronic 
suppurative otitis media (CSOM), continuous or intermittent otorrhea is present due to a 
perforation in the tympanic membrane.[1, 22] This study and review of literature focus 
on AOM. 
2.2 Epidemiology of acute otitis media 
2.2.1 Incidence 
AOM occurs worldwide, affecting especially pediatric populations. Among children, 
AOM is the most common reason for the prescription of antibiotics, and along with URIs, 
the leading cause for doctors’ visits.[1, 2] Based on a systematic review and hypothetical 
model, Monasta et al. estimated 709 million AOM episodes to occur each year, 51% of 
these among children under 5 years of age. There is large variation in the incidence and 
prevalence of OM between regions: the study group calculated the global incidence rate 
of AOM (new episodes per 100 person-years) to range from 4 in Central and Eastern 
Europe to 43 in Western and Central Sub-Saharan Africa. In Western Europe, including 
Finland, the incidence rate was estimated to be 6, i.e. slightly higher than in other parts 
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of Europe. Globally, the incidence rates were highest in the youngest age groups: 61 
among 1-4-year-olds and 45 in the under 1-year age group.[23] Indeed, a Finnish review 
summarizing the results of Scandinavian and Northern American studies reported the 
incidence of AOM to be highest at the age of 6-24 months, with the peak incidence at 10-
12 months.[20] Birth cohort studies have suggested that more than 60% and 80% of the 
children experience at least one AOM episode by the age of two and three years, 
respectively.[24, 25]  
Experiencing AOM at an early age increases the risk of recurrent AOM later on.[7]  For 
example, a Danish birth cohort study found that children who experienced their first AOM 
episode under the age of six months were more likely to encounter four or more AOM 
episodes by the age of seven years than those whose first AOM episode occurred at a later 
age.[26]  
2.2.2 Risk factors 
In addition to young age, several other risk factors for AOM have been identified. 
Regarding environmental risk factors, a meta-analysis published more than 20 years ago 
suggested day care attendance, having one or more siblings, parental smoking, pacifier 
use and positive family history of OM to be risk factors for the occurrence and recurrence 
of AOM.[27]  The meta-analysis also suggested breastfeeding to protect from OM. 
However, this finding has later been questioned. While some studies have linked male 
sex and low socioeconomic status with OM, others have not been able to confirm these 
findings. In addition, adenoid hypertrophy, allergy and atopy, weight, gastroesophageal 
reflux disease and vitamin D appear to be associated with OM.[26, 28-30] Heritability 
also plays a role, especially in rAOM and COME.[31]  
2.3 Pathogenesis of acute otitis media 
URI is undoubtedly one of the most important risk factors of AOM, as most cases of 
AOM occur simultaneously with or after URI.[5, 32] More than 9 out of 10 children with 
AOM experience concurrent URI symptoms. Furthermore, during AOM episodes, 
respiratory viruses are found in the majority of nasopharyngeal samples and up to 70% 
of middle ear specimens also test positive for these viruses.[9]   
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Indeed, respiratory viruses play an important role in the development of AOM. These 
viruses cause inflammation of the nasopharynx and Eustachian tube (ET), which connects 
the middle ear to the nasopharynx. This, in turn, leads to the generation of host 
inflammatory and immune responses. In addition, viral infections increase bacterial 
colonization and the adherence of bacteria to epithelial cells in the nasopharynx. The 
inflammatory and immune responses lead to swelling of the nasopharyngeal mucosa, 
diminished mucociliary clearance, obstruction of the ET and negative middle ear 
pressure. This facilitates the entrance of colonizing bacteria as well as viruses into the 
middle ear where inflammation develops, leading ultimately to the production of middle 
ear fluid (MEF), and signs and symptoms of AOM.[33]  
2.4 Etiology of acute otitis media 
As explained previously, AOM is considered a polymicrobial disease, in which bacteria 
and viruses interact in the pathogenesis.[9, 34] The role of bacteria in the pathogenesis of 
AOM is well established. The three most frequent bacterial pathogens of AOM, 
Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae, belong 
to the normal flora and colonize the nasopharynx from an early age.[35] These pathogenic 
bacteria cause disease only when the milieu of the nasopharynx changes, most often as a 
consequence of viral URI. There is not much geographical variation in bacterial 
pathogens causing OM. A recently performed systematic review studying the frequency 
of detection of bacteria in MEF specimens obtained from children experiencing OM 
suggested that, globally, S. pneumoniae is most commonly found during AOM (26.4-
30.2% of MEF samples), and it is closely followed by H. influenzae (22.2-27.8% of MEF 
samples). The detection rates of M. catarrhalis, on the other hand, range from 2.7% in 
South America to 11.6% and 13.8% in Europe and North America, respectively. Other 
bacteria less commonly found in patients with AOM include Streptococcus pyogenes, 
Staphylococcus aureus and Pseudomonas aeruginosa.[36]   
The role of viruses in the development of AOM is equally important, however, as virtually 
any virus causing URI can lead to the development of AOM. Some studies have suggested 
certain viruses to be more likely to cause AOM, and some viruses have been shown to 
cause AOM also without bacterial coinfection. The detection rates of different viruses 
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during AOM have varied between studies, depending e.g. on the study setting, detection 
technique used, viruses included in the assay, and timing of the study period. Viruses 
frequently linked to AOM include respiratory syncytial virus (RSV), influenza virus, 
parainfluenza virus, adenovirus, coronavirus, polyomavirus, human bocavirus (HBoV), 
metapneumovirus, and picornaviruses.[3, 9, 10, 13, 14, 37-39]   
The association between RSV, influenza and parainfluenza viruses, adenovirus, 
enterovirus and AOM has already been seen in earlier studies relying on viral culture 
and/or antigen detection methods.[38, 40] Newer studies based on more sensitive 
molecular detection methods have suggested also other viruses to be of importance in the 
development of AOM. An Australian hospital-based case-control study investigating the 
microbiology of rAOM in children undergoing surgery for the installation of 
tympanostomy tubes found HRV, HBoV, polyomaviruses, parainfluenza viruses, 
adenovirus, and RSV significantly more often in the nasopharynx of children with a 
history of rAOM compared to healthy controls.[14] A prospective, longitudinal study of 
infants in the first year of life assessing the prevalence and risks for URTI and AOM 
found that AOM development was associated with RSV, HRV, HEV, adenovirus and 
HBoV infection, and the rate of AOM complicating URTI in this age group was 27%. Of 
these viruses, RSV has been found to be associated with increased risk of AOM (OR 
6.50) without concurrent presence of bacterial copathogens, emphasizing the independent 
role of RSV in the pathogenesis of AOM.[10]  
More recent studies utilizing PCR-based detection methods have also provided more 
information on the role of picornaviruses in AOM. HRVs, HEVs and HPeVs will be 
discussed separately in the following chapters. It should be noted, however, that some 
controversy exists regarding the significance of the positive findings of these more 
sensitive molecular methods. This is discussed in chapter 2.5.2. 
2.4.1 Human rhinovirus 
As HRVs are among the most common causes of URI, accounting for up to 73% of all 
respiratory infections recorded during the first year of life [11, 12], it can be expected that 
HRVs play a significant role also in the development of AOM. Indeed, HRVs have been 
linked to AOM in a number of studies. In the previously mentioned study carried out 
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among 0-12-month-old infants living in the United States, HRV was the most common 
virus detected during URI and accounted for 40% of all detected viruses. HRV was 
significantly associated with the development of AOM (OR 5.08), which complicated 
27% of all URI episodes.[3] In the Australian hospital-based study, HRV was 
predominant in the middle ear and was detected in MEF samples of 46% of children with 
rAOM.[14] Similarly, in a recent birth cohort study conducted in South-Western Finland, 
HRV was associated with 50% of AOM episodes diagnosed among children aged 0-2 
years.[41]  
2.4.2 Human enterovirus 
Compared to HRVs, HEVs appear to play a somewhat smaller role in the development 
of AOM. A Finnish study including children with otorrhea from tympanostomy tubes, 
detected enteroviruses with PCR in 10% of the subjects.[9] The aforementioned study 
conducted in the United States found HEV to account for 11% of all detected viruses 
among symptomatic and asymptomatic 0-12-month-old infants. HEV was marginally 
associated with the development of AOM, however, HEV was also found in 
asymptomatic individuals.[3] The Finnish Otitis Media Vaccine Trial, a randomized, 
double-blinded cohort study, utilized PCR for the detection of picornaviruses in MEF and 
nasopharyngeal aspirate samples. HEVs were the second most common viruses found (in 
25% of AOM events) after HRVs (32%). It is noteworthy, however, that other viruses 
included in the study were sought by less sensitive antigen detection methods, hence the 
role of picornaviruses in this study may have been overestimated.[13]  
2.4.3 Human parechovirus 
More recently, HPeVs have also been suggested to play a role in the development of 
AOM. A small Finnish birth cohort study found 11% and 15% of MEF and 
nasopharyngeal aspirate samples to be PCR positive for HPeV, and HPeV seropositivity 
was associated with OM.[17]  Similarly, HPeV infection was diagnosed in the MEF, nasal 
cavity and/or stool in 14% of AOM cases in a prospective, out-patient-based study 
conducted in Finland.[16] A retrospective study conducted in the Netherlands found that 
19% of children under the age of five years who tested positive for HPeV type 4-6 in 
fecal samples, had otitis media.[15]   
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2.5 Diagnosis of acute otitis media 
2.5.1 Clinical diagnosis 
In clinical practice, the diagnosis of AOM is based on three criteria: acute symptoms of 
infection, signs of middle ear inflammation and presence of MEE.[20, 42] According to 
the Finnish Current Care Guidelines, the verification of signs of inflammation on the 
tympanic membrane and presence of MEE is done with pneumatic otoscopy performed 
by a doctor.[20]  Pneumatic otoscopy includes the visual assessment of the mobility and 
appearance of the tympanic membrane. It can be supplemented with tympanometry, a 
quantitative method of evaluating the mobility of the tympanic membrane and middle ear 
function.[1]  If a tympanostomy tube has been inserted or in the case of perforation of the 
tympanic membrane, the diagnosis of AOM is based on the detection of otorrhea through 
the tube or perforation.[20] 
2.5.1 Microbiological diagnosis 
In every day practice, the diagnosis of AOM is based solely on clinical evaluation, and 
the decision to treat is usually made without microbiological information on the cause of 
the infection. In Finland, microbiological samples are recommended to be considered in 
the case of AOM in children with otorrhea through a previously inserted tympanostomy 
tube. Similarly, MEF samples are recommended to be obtained through tympanocentesis 
(puncture of the tympanic membrane) from children with immunocompromising 
conditions, with suspected complications of AOM, or requiring hospitalization.[20]  
While tympanocentesis is not suitable for every day practice, other sample types such as 
nasopharyngeal swabs and aspirates, and even stool samples could be considered for 
assessing the pathogens potentially causing AOM episodes. As viral URI and 
nasopharyngeal carriage of certain pathogenic bacteria are strongly associated with the 
development of AOM, nasopharyngeal samples would be the logical, more feasible 
diagnostic tool of choice. Indeed, numerous studies assessing the microbiology of AOM 
have utilized nasal or nasopharyngeal specimens, either alone or in combination with 
MEF samples.[3-5, 13, 16, 37, 38] In the Finnish Otitis Media Cohort Study and the 
Finnish Otitis Media Vaccine Trial, the same virus was detected in both MEF and 
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nasopharyngeal aspirate specimens in 41% and 49% of the virus-positive AOM events, 
respectively. In the former study, HRV, influenza virus A and RSV were found 
concurrently in both sample types in 36%, 40% and 59% of the virus-positive events, 
respectively. In the latter study, the concurrence for HRV, HEV and RSV was 42%, 42% 
and 61%, respectively. In both studies, MEF samples were more often positive for these 
viruses than nasopharyngeal samples.[13] Hence, the choice of specimen type may have 
an impact on the number of virus-positive findings, as well as the variety of pathogens 
that can be detected. This was true for a smaller Finnish study assessing the presence of 
AOM pathogens in three specimen types: MEF, nasal swabs and stool samples. HPeV 
was detected in at least one of the sample types in 12 subjects (14%), and the specimen 
most commonly positive for HPeV was stool (50%). In only one of the subjects HPeV 
could be found in two sample types, namely MEF and stool.[16] This finding is 
understandable, as stool specimens have been considered as the classical sample type for 
HEVs and HPeVs replicating primarily in the intestinal and oropharyngeal mucosa.[43, 
44] Also HRVs have been detected frequently in stool samples.[45]   
After the sample or samples of choice have been obtained, several analytical methods can 
be utilized for the detection of AOM pathogens. Studies using conventional methods, 
including bacterial and viral cultures and antigen detection methods, have suggested 
bacteria alone to be the leading cause of AOM, and viruses to play only a minor role.[46] 
These methods, however, have been criticized for being vulnerable and unsensitive. 
Furthermore, certain viruses commonly causing URI, such as coronavirus, human 
metapneumovirus and HBoV cannot be detected with conventional methods.[46] The use 
of molecular diagnostics such as PCR assays has increased the sensitivity for viral 
detection and enabled the detection of viruses not identifiable by culture. Consequently, 
studies utilizing molecular methods have suggested the majority of AOM episodes to be 
caused by bacteria and viruses together, and viruses alone have also been suggested to 
lead to the development of AOM.[9]   
However, as Chonmaitree et al.[46] point out, the use of more sensitive methods has 
raised questions regarding the true pathogenicity of the detected viruses. Firstly, the 
detection of multiple viruses simultaneously has led to difficulties in determining which 
one of the detected viruses is the actual pathogen behind the symptoms. Secondly, nucleic 
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acids of certain viruses, including HRVs and HEVs, have been detected repeatedly in 
respiratory samples collected from children, which indicates prolonged presence of these 
viruses in the respiratory tract. Lastly, respiratory viruses have been commonly found in 
asymptomatic individuals as well, which could either suggest acute asymptomatic 
infection, recent symptomatic infection with prolonged shedding of the virus or viral 
persistence from previous infection.[3] Indeed, in two prospective longitudinal studies, 
viruses were detected in 27-40% of respiratory samples obtained during asymptomatic 
periods.[3, 47] Even though one of these studies found that asymptomatic viral infection 
did not result in the development of AOM [3], the significance of viral findings in 
respiratory samples during AOM remains somewhat controversial.    
2.6 Treatment of acute otitis media 
Traditionally, antibiotics have been the cornerstone of the treatment of AOM, and AOM 
continues to be the most common reason for children to consume antibiotics.[48]  
However, according to a recently updated systematic review and meta-analysis, most 
cases of AOM in high income countries heal spontaneously without complications, and 
antibiotics may only slightly speed up the resolution of symptoms.[49] This conclusion 
is supported by the previously presented information on the importance of viruses in 
AOM. Indeed, some cases of AOM may not require antibiotic therapy as AOM may be 
caused by viruses alone. It is also possible that the MEE containing bacteria and viruses 
may drain spontaneously in a few days’ time through the Eustachian tubes once the 
function of the tubes has returned to normal.[33]   
Recent studies and guidelines emphasize accurate diagnosis of AOM, effective treatment 
of ear pain and consideration of antibiotic therapy on an individual basis. Factors 
supporting antibiotic therapy include age less than two years, bilateral infection, otorrhea, 
bulging tympanic membrane and severe symptoms (ear pain 48h, fever 39C). 
Watchful waiting can be considered for children with non-severe symptoms and unilateral 
disease, provided that the clinical status of the child can be reassessed after 2-3 days if 
symptoms persist. Amoxicillin is considered the first-line choice of antibiotic, followed 
by amoxicillin-clavulanate. Options for pain management include paracetamol, 
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ibuprofen, naproxen or local anesthetics.[20, 42] As viral infections generally resolve 
spontaneously, the use of antiviral drugs is not recommended. 
2.7 Prevention of acute otitis media 
Considering the pathogenesis and etiology, the prevention of AOM episodes is ultimately 
based on the prevention of viral URI and reduction or prevention of nasopharyngeal 
carriage of bacterial otopathogens. To achieve this, current guidelines emphasize the 
reduction of environmental risks, and encourage the use of bacterial and viral 
vaccines.[20, 42]   
2.7.1 Environmental risk factors 
Regarding environmental risk factors, the American Academy of Pediatrics (AAP) 
recommends clinicians to encourage exclusive breastfeeding for at least six months and 
avoidance of tobacco smoke exposure.[42] The Finnish Current Care Guidelines also 
identify daycare attendance and pacifier use as possible targets for intervention.[20]  
2.7.2 Vaccines 
The polymicrobial nature of AOM poses significant challenges to the development and 
use of vaccines for preventive purposes. Of the three most important bacterial 
otopathogens, only vaccines against S. pneumoniae are currently widely available and 
used. The authors of a recently published systematic review[50] concluded that 
pneumococcal conjugate vaccines (PCVs), which have been used since year 2000, are 
somewhat effective for the prevention of pneumococcal OM and OM visits, as well as 
rOM and tympanostomy tube insertions. However, widespread use of PCVs has also been 
linked with changes observed in the distribution of other bacterial AOM pathogens and 
pneumococcal serotypes, with those not included in PCVs becoming more prevalent and 
thus reducing the effectiveness of PCVs against AOM. Despite this, the AAP strongly 
recommends the administration of PCV to all children.[42]  While the 10-valent PCV 
containing H. influenzae protein D seems effective against pneumococcal AOM, its’ 
effectiveness against AOM caused by H. influenzae is questionable. Other types of 
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vaccines against H. influenzae and M. catarrhalis also are being developed, but progress 
has been limited.[50]  
As viruses play a significant role in the development of AOM, preventing viral URIs with 
vaccines would likely prevent AOM too. Currently, the only AOM-associated respiratory 
virus vaccine that is licensed and widely used is the influenza vaccine. A recently 
published systematic review suggested that the influenza vaccine may reduce the 
incidence of AOM in infants and small children[51], and the use of influenza vaccines is 
encouraged in Finnish and American AOM guidelines.[20, 42] Some other respiratory 
viruses, such as RSV and picornaviruses, have also been targeted in terms of vaccine 
development. While vaccines against RSV[52]  and certain enteroviruses[53]  have 
already been developed, attempts to produce an HRV vaccine have failed[54], and the 
effectiveness of the more successful vaccine candidates against AOM is not known. 
However, the findings of our previous study were encouraging: we found that the oral 
polio vaccine (OPV), a live attenuated enterovirus vaccine, may reduce the incidence of 
AOM by providing cross-protection from non-polio enteroviruses and other 
picornaviruses that have been associated with AOM.[55]  
In conclusion, preventive methods are essential in reducing the burden of AOM on young 
children and their families. Verifying the significance of specific viruses in AOM would 
assist in the development of optimal antiviral strategies.  
  
 13 
3. WORK DESCRIPTION 
I began actively working on this study in the summer of 2016. Originally, this study was 
meant to be included in my doctoral dissertation only. Thus, the supervisor of my doctoral 
studies in the Doctoral Programme of Medicine and Life Sciences, professor Heikki 
Hyöty, had an important role in planning the study. Later, when the decision was made 
to include this study also in my master’s thesis, Sami Oikarinen became my other 
supervisor. He also had a significant role in planning the study. Subas Neupane kindly 
accepted my request to be the other supervisor of this thesis. 
The data collection period of the DIABIMMUNE study had already ended in October 
2013, and all data collected during the visits to the study clinics and recorded by parents 
in the diaries had been saved in the DIAIMMUNE study database. After we had made 
the decision to include all Finnish and Estonian DIABIMMUNE study participants in this 
piece of work, I retrieved all data available on these subjects from the database, 
reorganized the data and created a Microsoft Excel -based database of my own. Iiris Tyni 
and Jussi Lehtonen assisted me with compiling the data on otitis media diagnoses, and 
Jussi Lehtonen was also responsible for merging the laboratory data with the dataset I had 
created. 
Due to the relatively complicated study setting, Jussi Lehtonen performed all statistical 
analyses while I observed closely. Luckily, I had the opportunity to influence the 
conduction of all statistical analyses and could request additional analyses any time 
additional questions arose, or possible errors emerged. Heikki Hyöty, Sami Oikarinen and 
Subas Neupane kindly provided their input regarding the presentation of the results, 
namely the design of the tables and graphs included in the article manuscript. 
I wrote the article manuscript on my own, utilizing literature I considered relevant to 
introduce and discuss the topic of our study. Sami Oikarinen informed me of the process 
used for the laboratory analyses of the nasal swab and stool samples obtained during the 
DIAIMMUNE study. Jussi Lehtonen checked the contents of the chapter describing the 
statistical methods. Sami Oikarinen and Subas Neupane also provided general feedback 
on the preliminary version of the article manuscript. After the submission of this thesis 
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and my version of the article manuscript, the manuscript will be circulated among the 
other authors to obtain more feedback.   
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